Login / Signup

A case of schizophrenia with relapsed catatonia successfully treated with blonanserin transdermal patch.

Minako HagikuraToshiya Inada
Published in: Neuropsychopharmacology reports (2023)
Although benzodiazepines or electroconvulsive therapy have been recommended as the first-line treatment of catatonic manifestation observed in psychiatric patients, this patient responded well to antipsychotic blonanserin. From the differential drug responses, catatonia may be the complex of heterogeneous conditions with different pathophysiologies.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • acute lymphoblastic leukemia
  • bipolar disorder
  • acute myeloid leukemia
  • prognostic factors
  • case report
  • emergency department
  • drug induced